Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats
- PMID: 22933821
- PMCID: PMC3784982
- DOI: 10.2967/jnumed.112.103523
Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats
Abstract
(18)F-fluoromisonidazole PET, a noninvasive means of identifying hypoxia in tumors, has been widely applied but with mixed results, raising concerns about its accuracy. The objective of this study was to determine whether kinetic analysis of dynamic (18)F-fluoromisonidazole data provides better discrimination of tumor hypoxia than methods based on a simple tissue-to-plasma ratio.
Methods: Eleven Dunning R3327-AT prostate tumor-bearing nude rats were immobilized in custom-fabricated whole-body molds, injected intravenously with (18)F-fluoromisonidazole, and imaged dynamically for 105 min. They were then transferred to a robotic system for image-guided measurement of intratumoral partial pressure of oxygen (Po(2)). The dynamic (18)F-fluoromisonidazole uptake data were fitted with 2 variants of a 2-compartment, 3-rate-constant model, one constrained to have K(1) equal to k(2) and the other unconstrained. Parametric images of the rate constants were generated. The Po(2) measurements were compared with spatially registered maps of kinetic rate constants and tumor-to-plasma ratios.
Results: The constrained pharmacokinetic model variant was shown to provide fits similar to that of the unconstrained model and did not introduce significant bias in the results. The trapping rate constant, k(3), of the constrained model provided a better discrimination of low Po(2) than the tissue-to-plasma ratio or the k(3) of the unconstrained model.
Conclusion: The use of kinetic modeling on a voxelwise basis can identify tumor hypoxia with improved accuracy over simple tumor-to-plasma ratios. An effective means of controlling noise in the trapping rate constant, k(3), without introducing significant bias, is to constrain K(1) equal to k(2) during the fitting process.
Conflict of interest statement
No other potential conflict of interest relevant to this article was reported.
Figures






Similar articles
-
A robotic system for 18F-FMISO PET-guided intratumoral pO2 measurements.Med Phys. 2009 Nov;36(11):5301-9. doi: 10.1118/1.3239491. Med Phys. 2009. PMID: 19994538 Free PMC article.
-
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1493-502. doi: 10.1016/j.ijrobp.2004.12.057. Int J Radiat Oncol Biol Phys. 2005. PMID: 15817355
-
Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.Mol Imaging Biol. 2017 Dec;19(6):893-902. doi: 10.1007/s11307-017-1083-9. Mol Imaging Biol. 2017. PMID: 28409339 Free PMC article.
-
Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.J Nucl Med. 2017 Jun;58(6):911-919. doi: 10.2967/jnumed.116.180422. Epub 2017 Feb 23. J Nucl Med. 2017. PMID: 28232611 Free PMC article. Clinical Trial.
-
18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.J Nucl Med. 2017 Oct;58(10):1567-1573. doi: 10.2967/jnumed.117.190892. Epub 2017 Mar 30. J Nucl Med. 2017. PMID: 28360207 Free PMC article.
Cited by
-
18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.J Nucl Med. 2015 Aug;56(8):1223-8. doi: 10.2967/jnumed.115.158717. Epub 2015 Jun 25. J Nucl Med. 2015. PMID: 26112020 Free PMC article.
-
Measurement of hypoxia-related parameters in three sublines of a rat prostate carcinoma using dynamic (18)F-FMISO-Pet-Ct and quantitative histology.Am J Nucl Med Mol Imaging. 2015 Jun 15;5(4):348-62. eCollection 2015. Am J Nucl Med Mol Imaging. 2015. PMID: 26269773 Free PMC article.
-
Kinetic modeling in PET imaging of hypoxia.Am J Nucl Med Mol Imaging. 2014 Sep 6;4(6):490-506. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 25250200 Free PMC article. Review.
-
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features.Radiother Oncol. 2018 Apr;127(1):36-42. doi: 10.1016/j.radonc.2017.11.025. Epub 2017 Dec 19. Radiother Oncol. 2018. PMID: 29273260 Free PMC article.
-
Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy.Sci Rep. 2016 Aug 22;6:31551. doi: 10.1038/srep31551. Sci Rep. 2016. PMID: 27546160 Free PMC article.
References
-
- Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996;56:941–943. - PubMed
-
- Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56:4509–4515. - PubMed
-
- Mottram JC. A factor of importance in the radio-sensitivity of tumours. Br J Radiol. 1936;9:606–614.
-
- Teicher BA, Holden SA, al-Achi A, Herman TS. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Cancer Res. 1990;50:3339–3344. - PubMed
-
- Nozue M, Lee I, Yuan F, et al. Interlaboratory variation in oxygen tension measurement by Eppendorf “Histograph” and comparison with hypoxic marker. J Surg Oncol. 1997;66:30–38. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources